Health
Maker seeking Indian trial of Novavax jab – 7NEWS.com.au
Vaccine maker, the Serum Institute of India, wants to trial the Novavax jab locally, to factor in genetic differences in its population.
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
General17 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News23 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News22 hours agoPalestine protesters forced into last-minute reroute
-
Business21 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?